Hjem › Kræft (alle typer) › Nevada
Kræft (alle typer) kliniske forsøg i Nevada
13 studier for Kræft (alle typer) søger deltagere på steder i Nevada.
Byer i Nevada
Officiel studietekst (engelsk)
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
- Comprehensive Cancer Centers of Nevada ( Site 1109), Las Vegas
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07209111A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Renown Health Medical Oncology, Reno
- Renown Office of Clinical Research, Reno
- Renown Regional Medical Center, Reno
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06989437A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Research Site, Reno
RekruttererFase 3
Alder 18 til 130 · Alle køn · Opdateret 8. sep. 2026 · NCT07647328A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Comprehensive Cancer Centers of Nevada, Las Vegas
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT06119581Project: Every Child for Younger Patients With Cancer
- Oncology Las Vegas - Henderson, Henderson
- University Medical Center of Southern Nevada, Las Vegas
- Sunrise Hospital and Medical Center, Las Vegas
- og 5 flere
RekruttererObservationsstudie
Op til 25 år · Alle køn · Opdateret 25. aug. 2026 · NCT02402244Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Women's Cancer Center of Nevada, Las Vegas
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 7. aug. 2026 · NCT06580314A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- Comprehensive Cancer Center of Nevada, Las Vegas
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 15. jul. 2026 · NCT06657144A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Renown Regional Medical Center /ID# 276049, Reno
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 8. jun. 2026 · NCT07005102Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
- Comprehensive Cancer Center of Nevada, Las Vegas
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. mar. 2026 · NCT06014658TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
- Cancer Care Specialists - Reno, Reno
RekruttererObservationsstudie
Alder 18 til 99 · Alle køn · Opdateret 24. feb. 2026 · NCT06207032GEMINI-NSCLC: NSCLC Biomarker Study
- OptumCare Cancer Care, Las Vegas
- Hope Cancer Care of Nevada, Las Vegas
- Cancer Care Specialists Reno, Reno
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 5. feb. 2026 · NCT05236114Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
- Women's Cancer Center of Nevada, Las Vegas
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 13. nov. 2025 · NCT05997017Prospective Study of oncRNA Stratification of Cancer by Size and Stage
- Renown Health, Reno
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 18. mar. 2025 · NCT05833360Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.